secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2021-09-02T23:59:59+00:00
Accession:  0001193125-21-264582
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Acadia CFO Elena Ridloff resigns; CEO Davis named principal financial officer
-----------------------------------------------------------------------------

- Elena Ridloff resigned as EVP and CFO effective September 10, 2021.
- CEO Stephen Davis appointed as principal financial officer.
- Mark Schneyer appointed interim CFO; remains SVP and Chief Business Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312521264582/0001193125-21-264582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312521264582/d206699d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-264582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer